Newly approved drug is a "game changer" for Stage 4 pancreatic cancer patients - Central Oregon Daily

Newly approved drug is a "game changer" for Stage 4 pancreatic cancer patients – Central Oregon Daily

August 27, 2026

Newly approved drug is a “game changer” for Stage 4 pancreatic cancer patients Central Oregon Daily
FDA Approves Drug for Pancreatic Cancer in Milestone for Treatment of Deadly Disease WSJ
FDA Approves RASONQUE™ (daraxonrasib) Pancreatic Cancer Action Network
FDA Approves RevMed’s Breakthrough Pill for Pancreatic Cancer Bloomberg
New Drug Approved by F.D.A. for Pancreatic Cancer Could Be First of Many The New York Times